Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- National Cancer Institute Neuro-Oncology Branch
Bethesda, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University of Pennsylvania/abramson Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Ut Md Anderson Cancer Center
Houston, Texas, United States
- University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Dec 2005
- Primary completion
- 18 Oct 2018
- Completion
- 24 Apr 2027
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 83
- Registry id
- NCT00268385
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.